Related references
Note: Only part of the references are listed.Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer
Alexios Matikas et al.
BRITISH JOURNAL OF CANCER (2022)
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer
N. Xenidis et al.
BRITISH JOURNAL OF CANCER (2013)
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
V. Georgoulias et al.
ANNALS OF ONCOLOGY (2012)
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
Emmanouil Saloustros et al.
BREAST CANCER RESEARCH (2011)
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
Michail Ignatiadis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer
N. Xenidis et al.
ANNALS OF ONCOLOGY (2007)
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients
Nikos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
